Skip to content

Multicenter prospective study of colorectal serrated lesions in the Asia-Pacific region

Multicenter prospective study of colorectal serrated lesions in the Asia-Pacific region - AP-Colon SL study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000042890
Enrollment
1000
Registered
2021-01-04
Start date
2021-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal serrated lesion

Interventions

Observation of the entire proximal colon using chromoendoscopy (indigo carmine) during total colonoscopy.

Sponsors

National Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The study participants will be average-risk individuals (age: 40-74 years) undergoing total colonoscopy (TCS) for colorectal cancer screening for the first time in their lives at the participating institutions, who will receive a full oral explanation of the study using written materials, and who will provide consent in writing. Both individuals undergoing their first TCS for screening purposes and those undergoing first TCS following a positive fecal occult blood test in colorectal cancer screening are included in this study.

Exclusion criteria

Exclusion criteria: 1) Presence of uncontrollable complications, including unstable angina, acute myocardial infarction, heart failure, chronic respiratory disease, bleeding tendency, that make it difficult to safely perform TCS. 2) Clinical symptoms that indicate colorectal cancer, such as hematochezia or abdominal pain. 3) History of treatment for colorectal cancer or colorectal tumor. 4) History of colorectal surgery in which colorectum was resected. (Surgery not involving resection of colorectum such as appendectomy for appendicitis is not included in exclusion criteria) 5) Being from a family with hereditary colorectal cancer. 6) Difficult to survey baseline factors using a questionnaire. 7) Does not provide written consent. 8) Otherwise determined to be unfit by an investigator.

Design outcomes

Primary

MeasureTime frame
Colorectal SSL (sessile serrated lesion)

Secondary

MeasureTime frame
Non-SSL colorectal lesions (including non-SSL colorectal serrated lesions, colorectal cancer, advanced colorectal neoplasia, and colorectal adenoma), Serrated polyposis syndrome

Countries

Japan,Asia(except Japan)

Contacts

Public ContactMasau Sekiguchi

National Cancer Center Hospital Cancer Screening Center/ Endoscopy Division

masekigu@ncc.go.jp03-3542-2511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026